The immunology of parasite infections in immunocompromised hosts

T. Evering, Louis M. Weiss

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Immune compromise can modify the severity and manifestation of some parasitic infections. More widespread use of newer immnosuppressive therapies, the growing population of individuals with immunocompromised states as well as the prolonged survival of these patients have altered the pattern of parasitic infection. This review article discusses the burden and immunology of parasitic infections in patients who are immunocompromised secondary to congenital immunodeficiency, malnutrition, malignancy, and immunosuppressive medications. This review does not address the literature on parasitic infections in the setting of HIV-1 infection.

Original languageEnglish (US)
Pages (from-to)549-565
Number of pages17
JournalParasite Immunology
Volume28
Issue number11
DOIs
StatePublished - Nov 2006

Fingerprint

Parasitic Diseases
Immunocompromised Host
Allergy and Immunology
Immunosuppressive Agents
Malnutrition
HIV Infections
HIV-1
Survival
Population
Neoplasms
Therapeutics

Keywords

  • Cancer
  • Chemotherapy
  • HTLV-1
  • Immunocompromised
  • Steriods
  • Transplantation

ASJC Scopus subject areas

  • Parasitology
  • Immunology

Cite this

The immunology of parasite infections in immunocompromised hosts. / Evering, T.; Weiss, Louis M.

In: Parasite Immunology, Vol. 28, No. 11, 11.2006, p. 549-565.

Research output: Contribution to journalArticle

@article{86bb7b28e05f4c61b430002beb6f6555,
title = "The immunology of parasite infections in immunocompromised hosts",
abstract = "Immune compromise can modify the severity and manifestation of some parasitic infections. More widespread use of newer immnosuppressive therapies, the growing population of individuals with immunocompromised states as well as the prolonged survival of these patients have altered the pattern of parasitic infection. This review article discusses the burden and immunology of parasitic infections in patients who are immunocompromised secondary to congenital immunodeficiency, malnutrition, malignancy, and immunosuppressive medications. This review does not address the literature on parasitic infections in the setting of HIV-1 infection.",
keywords = "Cancer, Chemotherapy, HTLV-1, Immunocompromised, Steriods, Transplantation",
author = "T. Evering and Weiss, {Louis M.}",
year = "2006",
month = "11",
doi = "10.1111/j.1365-3024.2006.00886.x",
language = "English (US)",
volume = "28",
pages = "549--565",
journal = "Parasite Immunology",
issn = "0141-9838",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - The immunology of parasite infections in immunocompromised hosts

AU - Evering, T.

AU - Weiss, Louis M.

PY - 2006/11

Y1 - 2006/11

N2 - Immune compromise can modify the severity and manifestation of some parasitic infections. More widespread use of newer immnosuppressive therapies, the growing population of individuals with immunocompromised states as well as the prolonged survival of these patients have altered the pattern of parasitic infection. This review article discusses the burden and immunology of parasitic infections in patients who are immunocompromised secondary to congenital immunodeficiency, malnutrition, malignancy, and immunosuppressive medications. This review does not address the literature on parasitic infections in the setting of HIV-1 infection.

AB - Immune compromise can modify the severity and manifestation of some parasitic infections. More widespread use of newer immnosuppressive therapies, the growing population of individuals with immunocompromised states as well as the prolonged survival of these patients have altered the pattern of parasitic infection. This review article discusses the burden and immunology of parasitic infections in patients who are immunocompromised secondary to congenital immunodeficiency, malnutrition, malignancy, and immunosuppressive medications. This review does not address the literature on parasitic infections in the setting of HIV-1 infection.

KW - Cancer

KW - Chemotherapy

KW - HTLV-1

KW - Immunocompromised

KW - Steriods

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=33750082344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750082344&partnerID=8YFLogxK

U2 - 10.1111/j.1365-3024.2006.00886.x

DO - 10.1111/j.1365-3024.2006.00886.x

M3 - Article

VL - 28

SP - 549

EP - 565

JO - Parasite Immunology

JF - Parasite Immunology

SN - 0141-9838

IS - 11

ER -